Annual Income Tax
$760.20 M
-$150.20 M-16.50%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual income tax is currently $760.20 million, with the most recent change of -$150.20 million (-16.50%) on 31 December 2023. During the last 3 years, it has risen by +$355.00 million (+87.61%). VRTX annual income tax is now -16.50% below its all-time high of $910.40 million, reached on 31 December 2022.VRTX Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Income Tax
$178.70 M
-$23.70 M-11.71%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly income tax is currently $178.70 million, with the most recent change of -$23.70 million (-11.71%) on 30 September 2024. Over the past year, it has increased by +$34.80 million (+24.18%). VRTX quarterly income tax is now -37.18% below its all-time high of $284.48 million, reached on 31 December 2020.VRTX Quarterly Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Income Tax
$739.40 M
+$34.80 M+4.94%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated TTM income tax is currently $739.40 million, with the most recent change of +$34.80 million (+4.94%) on 30 September 2024. Over the past year, it has dropped by -$99.90 million (-11.90%). VRTX TTM income tax is now -21.45% below its all-time high of $941.30 million, reached on 30 June 2023.VRTX TTM Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Income Tax Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -16.5% | +24.2% | -11.9% |
3 y3 years | +87.6% | -22.6% | +29.3% |
5 y5 years | +151.1% | +1259.1% | +154.0% |
VRTX Income Tax High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -16.5% | +95.8% | -30.7% | +77.3% | -21.4% | +90.4% |
5 y | 5 years | -16.5% | +151.1% | -37.2% | +260.7% | -21.4% | +154.0% |
alltime | all time | -16.5% | +151.1% | -37.2% | +112.0% | -21.4% | +149.7% |
Vertex Pharmaceuticals Incorporated Income Tax History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $178.70 M(-11.7%) | $739.40 M(+4.9%) |
June 2024 | - | $202.40 M(+12.8%) | $704.60 M(-5.8%) |
Mar 2024 | - | $179.50 M(+0.4%) | $748.00 M(-1.6%) |
Dec 2023 | $760.20 M(-16.5%) | $178.80 M(+24.3%) | $760.20 M(-9.4%) |
Sept 2023 | - | $143.90 M(-41.5%) | $839.30 M(-10.8%) |
June 2023 | - | $245.80 M(+28.2%) | $941.30 M(+3.5%) |
Mar 2023 | - | $191.70 M(-25.7%) | $909.40 M(-0.1%) |
Dec 2022 | $910.40 M(+134.5%) | $257.90 M(+4.9%) | $910.40 M(+20.9%) |
Sept 2022 | - | $245.90 M(+15.0%) | $753.30 M(+2.0%) |
June 2022 | - | $213.90 M(+11.0%) | $738.30 M(+78.7%) |
Mar 2022 | - | $192.70 M(+91.2%) | $413.20 M(+6.4%) |
Dec 2021 | $388.30 M(-4.2%) | $100.80 M(-56.3%) | $388.30 M(-32.1%) |
Sept 2021 | - | $230.90 M(-307.6%) | $571.98 M(+36.3%) |
June 2021 | - | -$111.20 M(-166.3%) | $419.52 M(-19.0%) |
Mar 2021 | - | $167.80 M(-41.0%) | $518.22 M(+27.9%) |
Dec 2020 | $405.20 M(+85.8%) | $284.48 M(+262.7%) | $405.20 M(+89.0%) |
Sept 2020 | - | $78.44 M(-727.5%) | $214.43 M(+43.8%) |
June 2020 | - | -$12.50 M(-122.8%) | $149.14 M(-32.6%) |
Mar 2020 | - | $54.78 M(-41.5%) | $221.35 M(+1.5%) |
Dec 2019 | $218.10 M(-114.7%) | $93.71 M(+612.7%) | $218.10 M(-115.9%) |
Sept 2019 | - | $13.15 M(-78.0%) | -$1.37 B(-0.4%) |
June 2019 | - | $59.71 M(+15.9%) | -$1.37 B(-3.5%) |
Mar 2019 | - | $51.53 M(-103.5%) | -$1.42 B(-4.3%) |
Dec 2018 | -$1.49 B(+1285.4%) | -$1.49 B(<-9900.0%) | -$1.49 B(-9396.4%) |
Sept 2018 | - | $8.05 M(-22.1%) | $15.99 M(-113.6%) |
June 2018 | - | $10.34 M(-181.7%) | -$117.96 M(-4.8%) |
Mar 2018 | - | -$12.66 M(-223.4%) | -$123.97 M(+15.5%) |
Dec 2017 | -$107.32 M | $10.26 M(-108.1%) | -$107.32 M(-14.2%) |
Sept 2017 | - | -$125.90 M(-3003.0%) | -$125.03 M(-9213.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2017 | - | $4.34 M(+8.8%) | $1.37 M(-91.0%) |
Mar 2017 | - | $3.98 M(-153.5%) | $15.16 M(-9.0%) |
Dec 2016 | $16.66 M(-45.1%) | -$7.45 M(-1581.7%) | $16.66 M(-26.7%) |
Sept 2016 | - | $503.00 K(-97.2%) | $22.74 M(-3.5%) |
June 2016 | - | $18.13 M(+230.5%) | $23.57 M(-33.7%) |
Mar 2016 | - | $5.49 M(-497.8%) | $35.57 M(+17.1%) |
Dec 2015 | $30.38 M(+336.6%) | -$1.38 M(-203.7%) | $30.38 M(-10.1%) |
Sept 2015 | - | $1.33 M(-95.6%) | $33.80 M(-5.8%) |
June 2015 | - | $30.13 M(>+9900.0%) | $35.89 M(+456.1%) |
Mar 2015 | - | $299.00 K(-85.4%) | $6.45 M(-7.2%) |
Dec 2014 | $6.96 M(-105.7%) | $2.04 M(-40.2%) | $6.96 M(+11.0%) |
Sept 2014 | - | $3.42 M(+393.4%) | $6.27 M(+16.0%) |
June 2014 | - | $693.00 K(-13.7%) | $5.40 M(+85.6%) |
Mar 2014 | - | $803.00 K(-40.6%) | $2.91 M(-102.3%) |
Dec 2013 | -$122.42 M(>+9900.0%) | $1.35 M(-47.1%) | -$128.21 M(-25.1%) |
Sept 2013 | - | $2.56 M(-242.0%) | -$171.28 M(+12.3%) |
June 2013 | - | -$1.80 M(-98.6%) | -$152.48 M(+16.7%) |
Mar 2013 | - | -$130.31 M(+212.3%) | -$130.62 M(>+9900.0%) |
Dec 2012 | -$275.00 K(-101.4%) | -$41.73 M(-295.4%) | -$275.00 K(-100.4%) |
Sept 2012 | - | $21.36 M(+6.4%) | $64.11 M(+329.9%) |
June 2012 | - | $20.06 M(>+9900.0%) | $14.91 M(-22.7%) |
Mar 2012 | - | $32.00 K(-99.9%) | $19.30 M(+0.2%) |
Dec 2011 | $19.27 M(>+9900.0%) | $22.66 M(-181.4%) | $19.27 M(-667.6%) |
Sept 2011 | - | -$27.84 M(-213.9%) | -$3.39 M(-113.9%) |
June 2011 | - | $24.45 M(>+9900.0%) | $24.45 M(>+9900.0%) |
Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
June 2010 | - | $0.00 | $0.00 |
Dec 1993 | $100.00 K | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual income tax?
- What is the all time high annual income tax for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual income tax year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly income tax?
- What is the all time high quarterly income tax for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly income tax year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM income tax?
- What is the all time high TTM income tax for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM income tax year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual income tax?
The current annual income tax of VRTX is $760.20 M
What is the all time high annual income tax for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual income tax is $910.40 M
What is Vertex Pharmaceuticals Incorporated annual income tax year-on-year change?
Over the past year, VRTX annual income tax has changed by -$150.20 M (-16.50%)
What is Vertex Pharmaceuticals Incorporated quarterly income tax?
The current quarterly income tax of VRTX is $178.70 M
What is the all time high quarterly income tax for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly income tax is $284.48 M
What is Vertex Pharmaceuticals Incorporated quarterly income tax year-on-year change?
Over the past year, VRTX quarterly income tax has changed by +$34.80 M (+24.18%)
What is Vertex Pharmaceuticals Incorporated TTM income tax?
The current TTM income tax of VRTX is $739.40 M
What is the all time high TTM income tax for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM income tax is $941.30 M
What is Vertex Pharmaceuticals Incorporated TTM income tax year-on-year change?
Over the past year, VRTX TTM income tax has changed by -$99.90 M (-11.90%)